Infective and inactivated filamentous phage as carriers for immunogenic peptides

Journal of Virological Methods

Volumn 183, Issue 1, 2012, Pages 63-68

  Samoylova, Tatiana I ^a   Norris, Mandy D ^a   Samoylov, Alexandre M ^a   Cochran, Anna M ^a   Wolfe, Karen G ^a   Petrenko, Valery A ^a   Cox, Nancy R ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Filamentous phage; Fusion peptides; Immunogenic peptide carrier; Landscape phage; Phage inactivation; UV inactivated

Indexed keywords

IMMUNOGENIC PEPTIDE; IMMUNOGLOBULIN G ANTIBODY; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANTIGENICITY; ARTICLE; AUTOCLAVE; BACTERIOPHAGE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FREEZING; HEATING; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPECTROPHOTOMETRY; SPECTROSCOPY; ULTRAVIOLET RADIATION;

ANIMALS; ANTIBODIES; DESICCATION; DISINFECTION; DRUG CARRIERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FREEZING; GENETIC VECTORS; HOT TEMPERATURE; INOVIRUS; MALE; MICE; SPERMATOZOA; ULTRAVIOLET RAYS; VACCINES, CONTRACEPTIVE; VACCINES, INACTIVATED; VACCINES, SYNTHETIC; VIRUS INACTIVATION;

ANIMALIA; MUS;

EID: 84860597096     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2012.03.032     Document Type: Article

References (37)

1. Aida Y., Pabst M.J. Removal of endotoxin from protein solutions by phase-separation using triton X-114. Journal of Immunological Methods 1990, 132:191-195.
2. Brigati J.R., Petrenko V.A. Thermostability of landscape phage probes. Analytical and Bioanalytical Chemistry 2005, 382:1346-1350.
3. Brigati J.R., Samoylova T.I., Jayanna P.K., Petrenko V.A. Phage display for generating peptide reagents. Current Protocols in Protein Science 2008, 18.19.11-18.19.27. John Wiley & Sons, Inc. J.E. Coligan, B.M. Dunn, D.W. Speicher, P.T. Wingfield (Eds.).
4. Budovskii E.I., Kostiuk G.V. Principles of selective inactivation of the virus genome. IV. The effect of UV-irradiation of phage MS2 on its binding with anti-MS2-immunoglobulins. Molecular Biology (Mosk) 1985, 19:1216-1222.
5. Clark J.R., March J.B. Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials. Trends in Biotechnology 2006, 24:212-218.
6. Day L.A., Wiseman R.L. A comparison of DNA packaging in the virions of fd, Xf, and Pf1. The Single-Stranded DNA Phages 1978, 605-625. Cold Spring Harbor Laboratory, Cold Spring Harbor. D.T. Denhardt, D. Dressler, D.S. Ray (Eds.).
7. De Berardinis P., Haigwood N.L. New recombinant vaccines based on the use of prokaryotic antigen-display systems. Expert Review of Vaccines 2004, 3:673-679.
8. De Berardinis P., Sartorius R., Caivano A., Mascolo D., Domingo G.J., Del Pozzo G., Gaubin M., Perham R.N., Piatier-Tonneau D., Guardiola J. Use of fusion proteins and procaryotic display systems for delivery of HIV-1 antigens: development of novel vaccines for HIV-1 infection. Current HIV Research 2003, 1:441-446.
9. Delmastro P., Meola A., Monaci P., Cortese R., Galfre G. Immunogenicity of filamentous phage displaying peptide mimotopes after oral administration. Vaccine 1997, 15:1276-1285.
10. Eriksson F., Culp W.D., Massey R., Egevad L., Garland D., Persson M.A., Pisa P. Tumor specific phage particles promote tumor regression in a mouse melanoma model. Cancer Immunology, Immunotherapy 2007, 56:677-687.
11. Eriksson F., Tsagozis P., Lundberg K., Parsa R., Mangsbo S.M., Persson M.A., Harris R.A., Pisa P. Tumor-specific bacteriophages induce tumor destruction through activation of tumor-associated macrophages. The Journal of Immunology 2009, 182:3105-3111.
12. Freeman A.G., Schweikart K.M., Larcom L.L. Effect of ultraviolet radiation on the Bacillus subtilis phages SPO2, SPP1 and phi 29 and their DNAs. Mutation Research 1987, 184:187-196.
13. Frenkel D., Katz O., Solomon B. Immunization against Alzheimer's beta -amyloid plaques via EFRH phage administration. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:11455-11459.
14. Frenkel D., Dewachter I., Van Leuven F., Solomon B. Reduction of beta-amyloid plaques in brain of transgenic mouse model of Alzheimer's disease by EFRH-phage immunization. Vaccine 2003, 21:1060-1065.
15. Gaubin M., Fanutti C., Mishal Z., Durrbach A., De Berardinis P., Sartorius R., Del Pozzo G., Guardiola J., Perham R.N., Piatier-Tonneau D. Processing of filamentous bacteriophage virions in antigen-presenting cells targets both HLA class I and class II peptide loading compartments. DNA and Cell Biology 2003, 22:11-18.
16. Grabowska A.M., Jennings R., Laing P., Darsley M., Jameson C.L., Swift L., Irving W.L. Immunisation with phage displaying peptides representing single epitopes of the glycoprotein G can give rise to partial protective immunity to HSV-2. Virology 2000, 269:47-53.
17. Hashemi H., Bamdad T., Jamali A., Pouyanfard S., Mohammadi M.G. Evaluation of humoral and cellular immune responses against HSV-1 using genetic immunization by filamentous phage particles: a comparative approach to conventional DNA vaccine. Journal of Virological Methods 2010, 163:440-444.
18. Hayes S., Gamage L.N., Hayes C. Dual expression system for assembling phage lambda display particle (LDP) vaccine to porcine Circovirus 2 (PCV2). Vaccine 2010, 28:6789-6799.
19. Houimel M., Dellagi K. Peptide mimotopes of rabies virus glycoprotein with immunogenic activity. Vaccine 2009, 27:4648-4655.
20. Khan N.C., Poddar R.K. Photodynamic inactivation of antigenic determinants of single-stranded DNA bacteriophage phi chi 174. Journal of Virology 1974, 13:997-1000.
21. Krag D.N., Shukla G.S., Shen G.P., Pero S., Ashikaga T., Fuller S., Weaver D.L., Burdette-Radoux S., Thomas C. Selection of tumor-binding ligands in cancer patients with phage display libraries. Cancer Research 2006, 66:7724-7733.
22. Kuzmicheva G.A., Jayanna P.K., Eroshkin A.M., Grishina M.A., Pereyaslavskaya E.S., Potemkin V.A., Petrenko V.A. Mutations in fd phage major coat protein modulate affinity of the displayed peptide. Protein Engineering Design and Selection 2009, 22:631-639.
23. Kuzmicheva G.A., Jayanna P.K., Sorokulova I.B., Petrenko V.A. Diversity and censoring of landscape phage libraries. Protein Engineering Design and Selection 2009, 22:9-18.
24. Manoutcharian K., Gevorkian G., Cano A., Almagro J.C. Phage displayed biomolecules as preventive and therapeutic agents. Current Pharmaceutical Biotechnology 2001, 2:217-223.
25. Minenkova O.O., Ilyichev A.A., Kishchenko G.P., Petrenko V.A. Design of specific immunogens using filamentous phage as the carrier. Gene 1993, 128:85-88.
26. Morales J., Martinez J.J., Manoutcharian K., Hernandez M., Fleury A., Gevorkian G., Acero G., Blancas A., Toledo A., Cervantes J., Maza V., Quet F., Bonnabau H., de Aluja A.S., Fragoso G., Larralde C., Sciutto E. Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis. Vaccine 2008, 26:2899-2905.
27. Morales J., de Aluja A.S., Martinez J.J., Hernandez M., Rosas G., Villalobos N., Hernandez B., Blancas A., Manoutcharian K., Gevorkian G., Cervantes J., Diaz A., Fleury A., Fragoso G., Larralde C., Sciutto E. Recombinant S3Pvac-phage anticysticercosis vaccine: simultaneous protection against cysticercosis and hydatid disease in rural pigs. Veterinary Parasitology 2011, 176:53-58.
28. Ren Z.J., Tian C.J., Zhu Q.S., Zhao M.Y., Xin A.G., Nie W.X., Ling S.R., Zhu M.W., Wu J.Y., Lan H.Y., Cao Y.C., Bi Y.Z. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice. Vaccine 2008, 26:1471-1481.
29. Sartorius R., Bettua C., D'Apice L., Caivano A., Trovato M., Russo D., Zanoni I., Granucci F., Mascolo D., Barba P., Pozzo G.D., Berardinis P.D. Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T-cell responses in the absence of adjuvants. European Journal of Immunology 2011, 41:2573-2584.
30. Synnott A., Ohshima K., Nakai Y., Tanji Y. IgA response of BALB/c mice to orally administered Salmonella typhimurium flagellin-displaying T2 bacteriophages. Biotechnology Progress 2009, 25:552-558.
31. Ulivieri C., Citro A., Ivaldi F., Mascolo D., Ghittoni R., Fanigliulo D., Manca F., Baldari C.T., Li Pira G., Del Pozzo G. Antigenic properties of HCMV peptides displayed by filamentous bacteriophages vs. synthetic peptides. Immunology Letters 2008, 119:62-70.
32. Wan Y., Wu Y., Zhou J., Zou L., Liang Y., Zhao J., Jia Z., Engberg J., Bian J., Zhou W. Cross-presentation of phage particle antigen in MHC class II and endoplasmic reticulum marker-positive compartments. European Journal of Immunology 2005, 35:2041-2050.
33. Wang L.F., Yu M. Epitope identification and discovery using phage display libraries: applications in vaccine development and diagnostics. Current Drug Targets 2004, 5:1-15.
34. Wang G., Sun M., Fang J., Yang Q., Tong H., Wang L. Protective immune responses against systemic candidiasis mediated by phage-displayed specific epitope of Candida albicans heat shock protein 90 in C57BL/6J mice. Vaccine 2006, 24:6065-6073.
35. Willis A.E., Perham R.N., Wraith D. Immunological properties of foreign peptides in multiple display on a filamentous bacteriophage. Gene 1993, 128:79-83.
36. Yang Q., Su Q.P., Wang G.Y., Wen D.Z., Zhang Y.H., Bao H.Z., Wang L. Production of hybrid phage displaying secreted aspartyl proteinase epitope of Candida albicans and its application for the diagnosis of disseminated candidiasis. Mycoses 2007, 50:165-171.
37. Yip Y.L., Smith G., Ward R.L. Comparison of phage pIII pVIII and GST as carrier proteins for peptide immunisation in Balb/c mice. Immunology Letters 2001, 79:197-202.